146 related articles for article (PubMed ID: 26918755)
21. The cytochromes P450 and b5 and their reductases--promising targets for structural studies by advanced solid-state NMR spectroscopy.
Dürr UH; Waskell L; Ramamoorthy A
Biochim Biophys Acta; 2007 Dec; 1768(12):3235-59. PubMed ID: 17945183
[TBL] [Abstract][Full Text] [Related]
22. CYP2C9 protein interactions with cytochrome b(5): effects on the coupling of catalysis.
Locuson CW; Wienkers LC; Jones JP; Tracy TS
Drug Metab Dispos; 2007 Jul; 35(7):1174-81. PubMed ID: 17446262
[TBL] [Abstract][Full Text] [Related]
23. Effect of Cytochrome b5 Content on the Activity of Polymorphic CYP1A2, 2B6, and 2E1 in Human Liver Microsomes.
Zhang H; Gao N; Liu T; Fang Y; Qi B; Wen Q; Zhou J; Jia L; Qiao H
PLoS One; 2015; 10(6):e0128547. PubMed ID: 26046844
[TBL] [Abstract][Full Text] [Related]
24. The optical biosensor studies on the role of hydrophobic tails of NADPH-cytochrome P450 reductase and cytochromes P450 2B4 and b5 upon productive complex formation within a monomeric reconstituted system.
Ivanov YD; Kanaeva IP; Kuznetsov VY; Lehnerer M; Schulze J; Hlavica P; Archakov AI
Arch Biochem Biophys; 1999 Feb; 362(1):87-93. PubMed ID: 9917332
[TBL] [Abstract][Full Text] [Related]
25. Substrate influence on interaction between cytochrome P450 and cytochrome b5 in microsomes.
Jansson I; Schenkman JB
Arch Biochem Biophys; 1996 Jan; 325(2):265-9. PubMed ID: 8561506
[TBL] [Abstract][Full Text] [Related]
26. Interactions of mammalian cytochrome P450, NADPH-cytochrome P450 reductase, and cytochrome b(5) enzymes.
Shimada T; Mernaugh RL; Guengerich FP
Arch Biochem Biophys; 2005 Mar; 435(1):207-16. PubMed ID: 15680923
[TBL] [Abstract][Full Text] [Related]
27. Functional interactions between cytochromes P450 1A2 and 2B4 require both enzymes to reside in the same phospholipid vesicle: evidence for physical complex formation.
Reed JR; Eyer M; Backes WL
J Biol Chem; 2010 Mar; 285(12):8942-52. PubMed ID: 20071338
[TBL] [Abstract][Full Text] [Related]
28. Phospholipid membranes affect tertiary structure of the soluble cytochrome b5 heme-binding domain.
Basova LV; Tiktopulo EI; Kutyshenko VP; Mauk AG; Bychkova VE
Biochim Biophys Acta; 2008 Apr; 1778(4):1015-26. PubMed ID: 18275841
[TBL] [Abstract][Full Text] [Related]
29. Kinetics of ferric cytochrome P450 reduction by NADPH-cytochrome P450 reductase: rapid reduction in the absence of substrate and variations among cytochrome P450 systems.
Guengerich FP; Johnson WW
Biochemistry; 1997 Dec; 36(48):14741-50. PubMed ID: 9398194
[TBL] [Abstract][Full Text] [Related]
30. The role of cytochrome b5 structural domains in interaction with cytochromes P450.
Sergeev GV; Gilep AA; Usanov SA
Biochemistry (Mosc); 2014 May; 79(5):406-16. PubMed ID: 24954591
[TBL] [Abstract][Full Text] [Related]
31. Theoretical investigation of differences in nitroreduction of aristolochic acid I by cytochromes P450 1A1, 1A2 and 1B1.
Jerabek P; Martinek V; Stiborova M
Neuro Endocrinol Lett; 2012; 33 Suppl 3():25-32. PubMed ID: 23353840
[TBL] [Abstract][Full Text] [Related]
32. Evidence that cytochrome b5 acts as a redox donor in CYP17A1 mediated androgen synthesis.
Duggal R; Liu Y; Gregory MC; Denisov IG; Kincaid JR; Sligar SG
Biochem Biophys Res Commun; 2016 Aug; 477(2):202-8. PubMed ID: 27297105
[TBL] [Abstract][Full Text] [Related]
33. Interactions among P450 enzymes when combined in reconstituted systems: formation of a 2B4-1A2 complex with a high affinity for NADPH-cytochrome P450 reductase.
Backes WL; Batie CJ; Cawley GF
Biochemistry; 1998 Sep; 37(37):12852-9. PubMed ID: 9737863
[TBL] [Abstract][Full Text] [Related]
34. Influence of ionic strength on the P450 monooxygenase reaction and role of cytochrome b5 in the process.
Schenkman JB; Voznesensky AI; Jansson I
Arch Biochem Biophys; 1994 Oct; 314(1):234-41. PubMed ID: 7944401
[TBL] [Abstract][Full Text] [Related]
35. Bilayer structure and physical dynamics of the cytochrome b5 dimyristoylphosphatidylcholine interaction.
Chester DW; Skita V; Young HS; Mavromoustakos T; Strittmatter P
Biophys J; 1992 May; 61(5):1224-43. PubMed ID: 1600082
[TBL] [Abstract][Full Text] [Related]
36. Sheep adrenal cytochrome b5: active as a monomer or a tetramer in vivo?
Lombard N; Swart AC; van der Merwe MJ; Swart P
Endocr Res; 2002 Nov; 28(4):485-92. PubMed ID: 12530653
[TBL] [Abstract][Full Text] [Related]
37. The effects of cytochrome b5, NADPH-P450 reductase, and lipid on the rate of 6 beta-hydroxylation of testosterone as catalyzed by a human P450 3A4 fusion protein.
Shet MS; Faulkner KM; Holmans PL; Fisher CW; Estabrook RW
Arch Biochem Biophys; 1995 Apr; 318(2):314-21. PubMed ID: 7733659
[TBL] [Abstract][Full Text] [Related]
38. Investigation of the rate limiting step for electron transfer from NADPH:cytochrome P450 reductase to cytochrome b5: a laser flash-photolysis study.
Bhattacharyya AK; Hurley JK; Tollin G; Waskell L
Arch Biochem Biophys; 1994 May; 310(2):318-24. PubMed ID: 8179314
[TBL] [Abstract][Full Text] [Related]
39. The role of cytosolic proteins in the insertion of tail-anchored proteins into phospholipid bilayers.
Colombo SF; Longhi R; Borgese N
J Cell Sci; 2009 Jul; 122(Pt 14):2383-92. PubMed ID: 19531581
[TBL] [Abstract][Full Text] [Related]
40. Kinetics of the reduction of cytochrome b5 with mutations in its membrane-binding domain.
Wu FF; Vergères G; Waskell L
Arch Biochem Biophys; 1994 Feb; 308(2):380-6. PubMed ID: 7906503
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
